| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $396.9M | $432.5M | $480.8M |
| YoY Revenue Growth % | -8.2% | -10.0% | — |
| Gross Profit | $226.2M | $249.9M | — |
| Gross Margin % | 57.0% | 57.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$113.2M | $740.0K | $6.8M |
| Operating Margin % | -28.5% | 0.2% | 1.4% |
| Net Income (GAAP) | -$119.4M | -$5.7M | $3.0M |
| EBITDA (Normalized) | -$110.8M | $3.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $21.1M | -$3.9M | $21.7M |
| Capital Expenditures (CapEx) | $3.0M | $3.4M | — |
| Free Cash Flow (FCF) | $18.1M | -$7.3M | $21.7M |
| FCF Margin % | 4.6% | -1.7% | 4.5% |
| Return on Invested Capital (ROIC %) | -45.0% | 0.3% | — |
| Cash & Short-Term Equivalents | $63.3M | $56.1M | — |
| Total Debt (Short + Long Term) | $0 | $35.0M | — |
| Total Stockholders' Equity | $126.5M | $229.5M | — |